Moleculin Biotech Shares Updates on AML Trial Progress in Virtual Investor Segment Moleculin Biotech participates in a virtual investor segment highlighting advancements in its pivotal AML trial, emphasizing the Annamycin treatment strategy.

Moleculin Biotech Shares Updates on AML Trial Progress in Virtual Investor Segment #USA #Houston #Moleculin_Biotech #Annamycin #AML_Trial